Prophylactic implantable cardioverterdefibrillator treatment in the elderly: Therapy, adverse events, and survival gain

Europace

Volumn 14, Issue 1, 2012, Pages 66-73

  Van Rees, Johannes B ^a   Willem Borleffs, C Jan ^a   Thijssen, Joep ^a   De Bie, Mihály K ^a   Van Erven, Lieselot ^a   Cannegieter, Suzanne C ^a   Bax, Jeroen J ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; Elderly; Implantable cardioverterdefibrillator; Primary prevention; Sudden cardiac death

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVERSION; DEATH; DEFIBRILLATOR; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART DEATH; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL RATE; TREATMENT OUTCOME; COHORT ANALYSIS; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INCIDENCE; MIDDLE AGED; STATISTICS; SURVIVAL;

AGED; ATRIAL FIBRILLATION; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SURVIVAL; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84055184411     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur255     Document Type: Article

References (35)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
5. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-63. (Pubitemid 33043293)
6. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-15. (Pubitemid 46962260)
7. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. Arch Intern Med 2010;170:631-7.
8. Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB et al. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: Time to go beyond the initial shock. J Am Coll Cardiol 2009;54:1993-2000.
9. Krahn AD, Connolly SJ, Roberts RS, Gent M. Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden death. Am Heart J 2004;147:837-40. (Pubitemid 38880994)
10. El-Chami MF, Hanna IR, Bush H, Langberg JJ. Impact of race and gender on cardiac device implantations. Heart Rhythm 2007;4:1420-6. (Pubitemid 47591397)
11. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT-II substudy. J Cardiovasc Electrophysiol 2007;18:833-8. (Pubitemid 47093069)
12. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-484.
13. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408. (Pubitemid 351771339)
14. Borleffs CJ, van Welsenes GH, van Bommel RJ, van der Velde ET, Bax JJ, van Erven L et al. Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. Eur Heart J 2010;31:712-8.
15. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708-13. (Pubitemid 33010364)
16. Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997;29:556-60. (Pubitemid 27116097)
17. van der Burg AE, Bax JJ, Boersma E, van Erven L, Bootsma M, van der Wall EE et al. Standardized screening and treatment of patients with life-threatening arrhythmias: The Leiden out-of-hospital cardiac arrest evaluation study. Heart Rhythm 2004;1:51-7. (Pubitemid 38647250)
18. Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ et al. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in highrisk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2006;17:931-6.
19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
20. Borleffs CJ, Thijssen J, de Bie MK, van Rees JB, van Welsenes GH, van Erven L et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol 2010;33:1013-9.
21. Maloney JD, Hayes DL, Timmis GC. Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The Writing Committee. Pacing Clin Electrophysiol 1993;16:1945-52. (Pubitemid 23306491)
22. Cheng A,Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol 2010;56:1651-6.
23. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
24. Myerburg RJ, Luceri RM, Thurer R, Cooper DK, Zaman L, Interian A et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;14:508-14. (Pubitemid 19199779)
25. From the Centers for Disease Control and Prevention. Public health and aging: Trends in aging-United States and worldwide. JAMA 2003;289:1371-3.
26. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De SG et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010;121:e46-215.
27. Epstein AE, Kay GN, Plumb VJ, McElderry HT, Doppalapudi H, Yamada T et al. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm 2009;6:1136-43.
28. Santangeli P, Di Biase L, Dello RA, Casella M, Bartoletti S, Santarelli P et al. Meta-analysis: Age and effectiveness of prophylactic implantable cardioverterdefibrillators. Ann Intern Med 2010;153:592-9.
29. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol 2005;14:169-73. (Pubitemid 43130288)
30. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-9. (Pubitemid 44396897)
31. Ertel D, Phatak K, Makati K, Holland M, Baig S, Kim MH et al. Predictors of early mortality in patients age 80 and older receiving implantable defibrillators. Pacing Clin Electrophysiol 2010;33:981-7.
32. Heidenreich PA, Tsai V. Is anyone too old for an implantable cardioverterdefibrillatoř Circ Cardiovasc Qual Outcomes 2009;2:6-8.
33. Strauss DG, Poole JE,Wagner GS, Selvester RH, Miller JM, Anderson J et al. An ECG index of myocardial scar enhances prediction of defibrillator shocks: An analysis of the sudden cardiac death in heart failure trial. Heart Rhythm 2011;8:38-45.
34. Desai H, Aronow WS, Ahn C, Gandhi K, Hussain S, Lai HM et al. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverterdefibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol 2010;105:1336-8.
35. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic?. Am J Cardiol 2006;97:1255-61.